PainReform Stock Quote PRFX - Stock Price, News, Charts, Message Board, Trades

Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
PainReform Ltd (PRFX) Quote

PainReform Ltd (PRFX)

0.6126

-0.0089

(-1.43%)

Closed October 02 4:00PM

Delayed by 15 minutes

0.62

0.0074

( 1.21% )

Pre Market: 9:14AM

Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.62

Bid

0.6125

Ask

0.63

Volume

351

0.00 Day's Range 0.00

0.57 52 Week Range 20.16

Market Cap

Previous Close

0.6126

Open

-

Last Trade

Last Trade Time

08:28:16

Financial Volume

-

VWAP

-

Average Volume (3m)

1,375,850

Shares Outstanding

1,171,041

Dividend Yield

-

PE Ratio

-0.08

Earnings Per Share (EPS)

-7.98

Revenue

-

Net Profit

-9.34M

PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.painreform.com

Headquarters

Herzliya, Center, Isr

Founded

-

PainReform Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PRFX. The last closing price for PainReform was $0.61. Over the last year, PainReform shares have traded in a share price range of $ 0.57 to $ 20.16.

PainReform currently has 1,171,041 shares outstanding. The market capitalization of PainReform is $717,379.72 . PainReform has a price to earnings ratio (PE ratio) of -0.08.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form F-3 - Registration statement by foreign private issuers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

TEL AVIV, Israel, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the...

PainReform Announces Exercise of Warrants for $1.58 Million Gross Proceeds

TEL AVIV, Israel, Sept. 10, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form EFFECT - Notice of Effectiveness

Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]

Form POS AM - Post-Effective amendments for registration statement

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.08	-11.4285714286	0.7	0.7	0.6	109614	0.62959507	CS
4	-0.5596	-47.4398101051	1.1796	1.8594	0.57	1484001	1.24410513	CS
12	-2.362	-79.2085848424	2.982	3.594	0.57	1375850	1.51192391	CS
26	-9.82	-94.061302682	10.44	15.3	0.57	765246	2.27912805	CS
52	-18.94	-96.8302658487	19.56	20.16	0.57	395943	2.59446442	CS
156	-174.58	-99.6461187215	175.2	175.2	0.57	332319	43.403933	CS
260	-399.58	-99.8450774613	400.2	470.4	0.57	382023	111.66635954	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AALAmerican Airlines Group Inc	$ 10.74 (0.00%)	157.54k
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.55 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.96 (0.00%)	1
AACGATA Creativity Global	$ 0.8955 (0.00%)	583
AALAmerican Airlines Group Inc	$ 10.74 (0.00%)	157.54k
AAGRAfrican Agriculture Holdings Inc	$ 0.1326 (0.00%)	0
AADRAdvisorShares Dorsey Wright ADR ETF	$ 63.55 (0.00%)	0
AADIAadi Bioscience Inc	$ 1.96 (0.00%)	1
AACGATA Creativity Global	$ 0.8955 (0.00%)	583
ELABElevai Labs Inc	$ 0.0852 (0.00%)	163.33M
PEGYPineapple Energy Inc	$ 0.1149 (0.00%)	97.64M
MLGOMicroAlgo Inc	$ 0.31 (0.00%)	40.07M
CDTConduit Pharmaceuticals Inc	$ 0.095 (0.00%)	26.8M
XPONExpion360 Inc	$ 0.0466 (0.00%)	10.25M

Monksdream

Monksdream 1 week ago

PRFX new 52 week low

Monksdream

Monksdream 2 weeks ago

PRFX new 52 week low

tw0122

tw0122 2 weeks ago

New reoffering couldn’t sell shares first time nor on new reduced price take it to
20 cents and do another reverse split. Bye bye shareholders this is the penny bio scam game

Awl416

Awl416 2 weeks ago

Awl416

Awl416 2 weeks ago

I would fall for it

Surfacetite

Surfacetite 3 weeks ago

Snagged some. Good pr

Awl416

Awl416 3 weeks ago

PainReform Ltd. Confirms Sutures Compatibility in Human Clinical Trials for PRF-110

glenn1919

glenn1919 4 weeks ago

PRFX...............................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783

Awl416

Awl416 1 month ago

That chart. Yikes…

it_happens

it_happens 1 month ago

Moving up nicely today

it_happens

it_happens 1 month ago

Doesn't look like it today

Surfacetite

Surfacetite 1 month ago

Can we break $1 again.

TheFinalCD

TheFinalCD 1 month ago

its much better to trade the front side of these runs, than trying to catch a dip and rip

otherwise you can get caught in one of these all day chop & grind, lower lows, Gap & Traps like PRFX

Ive learned too many le$$ons the hard way

Tool_power

Tool_power 1 month ago

stock1ace1

stock1ace1 1 month ago

Invest-in-America

Invest-in-America 1 month ago

PRFX: Hey, Bro, the ONLY "PainReform" this Israel company must engage is the termination of the Hitler-like SLAUGHTER of patently-innocent Arabic kids, adults, seniors, & their pet cats & dogs.

Tool_power

Tool_power 1 month ago

Catching a bid @ .33

madras50

madras50 1 month ago

Awl416

Awl416 1 month ago

TheFinalCD

TheFinalCD 1 month ago

glenn1919

glenn1919 1 month ago

PRFX.................................https://stockcharts.com/h-sc/ui?s=PRFX&p=W&b=5&g=0&id=p86431144783

Invest-in-America

Invest-in-America 1 month ago

PRFX: Its ISRAEL headquarters ruined this!!! (FUCK that damn nation!!)

tw0122

tw0122 1 month ago

Printing dilution shares faster then the Federal Reserve prints cash . They are Gangsta

TrendTrade2016

TrendTrade2016 1 month ago

incoming attack from enemy drones....

it_happens

it_happens 1 month ago

Kind of like a yoyo this morning. Think it will go back up?

TheFinalCD

TheFinalCD 1 month ago

TOOK SOME .59'S HPW BOUT U

TrendTrade2016

TrendTrade2016 1 month ago

dilution up...cash down...warrants and s-1s galore~!

tw0122

tw0122 1 month ago

TrendTrade2016

TrendTrade2016 1 month ago

ouch...dilution brings it down fast

TheFinalCD

TheFinalCD 1 month ago

1.17 -.64 IS RUDE

Awl416

Awl416 1 month ago

TheFinalCD

TheFinalCD 1 month ago

tw0122

tw0122 1 month ago

Join the hedgies lol .95 + 200%

TheFinalCD

TheFinalCD 1 month ago

https://healthstockshub.com/news/nyseamex/igc/igc-pharma-expands-drug-portfolio-to-metabolic-disorders-with-igc-1a-a-potential-new-glp-1-agonist

https://dilutiontracker.com/app/search/PRFX?a=dbb88c

Awl416

Awl416 1 month ago

PainReform Announces Positive Safety Profile for PRF-110 in Phase 3 Bunionectomy Study

Monksdream

Monksdream 2 months ago

PRFX new 52 week low

Monksdream

Monksdream 2 months ago

PRFX new 52 week low

FALCON1

FALCON1 2 months ago

https://www.zacks.com/stock/news/2300964/the-zacks-analyst-blog-highlights-danaher-morgan-stanley-pfizer-elite-pharmaceuticals-and-oil-dri

https://www.zacks.com/stock/news/2300922/zacks-initiates-coverage-of-elite-pharmaceuticals-with-outperform-recommendation

Sirpeter

Sirpeter 2 months ago

I'm out again...was too early...it will have its day by Y/E

Monksdream

Monksdream 2 months ago

PRFX new 52 week low

Tool_power

Tool_power 2 months ago

What the heck is happening here? Capitulation? Ex-CEO Hadar dumping?

Or, in a best case scenario MMs are looking for inventory before a run. Dip and rip is common. Time will tell.

Sirpeter

Sirpeter 3 months ago

... heading for the promised land...just starting

Sirpeter

Sirpeter 3 months ago

...all I know is this is way oversold and the product seems to be working...to be honest Im here for a quick trade...I make the big money playing options

Tool_power

Tool_power 3 months ago

We should get a bump, especially if the promising results in April are confirmed (96 hr pain relief Vs. 72 hr, and better performance than the leading competitor product).

But Hadar was saying that after these clinical trials for Bunionectomy (hard tissue) were concluded that they would then do the Hernia operation (soft tissue) clinical trials in 2025 with planned NDA submission in 2026. I wonder if that strategy will change now?

Sirpeter

Sirpeter 3 months ago

Dont know...doesnt matter as long as the last phase of the drug trial is happening...we should get a bump soon

Tool_power

Tool_power 3 months ago

Interesting that CEO Hadar stepped down. I have no problem with this as I didn’t think he was very good, but I wonder why he made this decision.

I have more confidence in Dr. Ehud Geller as the interim.

Sirpeter

Sirpeter 3 months ago

Added some today...low enough...dont see any danger of RS...will be past $1 soon enough

Monksdream

Monksdream 4 months ago

PRFX new 52 week low

Sirpeter

Sirpeter 4 months ago

Think we have to wait for more news on this one...need to know whwn drug trial ends...maybe around Sept

Tiger Money

Tiger Money 4 months ago

Taking off a little bit now

Delayed Upgrade Clock